Skip to main content
Caplight Logo









GenesInk

GenesInk

Private
RoussetFrontier & Industrial Techhttps://www.genesink.com/

Last Round

Recap

Dec 31, 2021

Total Funding Raised

$1.91M

Company Overview

GenesInk is a materials science company that manufactures conductive and semi-conductive nano-inks for printed electronics, IoT, and display applications.

Sector

Frontier & Industrial Tech

Verticals

Advanced Materials, Consumer Electronics, Renewable Energy, IoT Hardware, Semiconductors

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

nano-inksprinted electronicsflexible electronicsconductive inkadditive manufacturingflexible circuitsorganic photovoltaicsOPVtransparent conductive layersprinted circuitsinkjet printingprinted techadvanced materialscustom formulationstretchable electronics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenesInk Comparables

Compare GenesInk with similar companies based on industry and business-model similarity.

GenesInk comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dycotec Materials
86%
C-INK Co., Ltd.
82%
NovaCentrix
82%

GenesInk Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
RecapDec 31, 2021
Private EquityDec 1, 2021
GrantNov 10, 2021
SeedJul 14, 2014

Key People

Founding team and executive leadership

Corinne VERSINI

Chief Executive Officer

Executive Team

GenesInk Investors

Notable investors and investment history

GenesInk investors
InvestorRounds
ADEME InvestissementGrant
CAAP CréationSeed
Corporatum OyRecap

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 16, 2025

    Grew 33% QoQ from 15 to 20 employees.

  • Sep 6, 2025

    Grew 31% QoQ from 13 to 17 employees.

GenesInk Filings

Explore SEC and related filing metadata, where available.

GenesInk filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GenesInk's valuation, stock price, and market status.

Is GenesInk a public or private company?

GenesInk is a private company.

What is the current stock price of GenesInk?

GenesInk is a private company, so its shares have no public market price. Caplight tracks GenesInk's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is GenesInk worth (valuation)?

Valuation information for GenesInk is not publicly available.

Can I buy GenesInk stock?

GenesInk shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was GenesInk's last funding round?

GenesInk's most recent funding round was Recap on December 31, 2021.

Who are the main investors in GenesInk?

Key investors in GenesInk include ADEME Investissement, CAAP Création, Corporatum Oy.

Will GenesInk IPO soon?

No public IPO plans have been announced for GenesInk.

How can I track GenesInk secondary market activity?

Caplight tracks bids, offers, and trades in GenesInk's shares on secondary markets.

Firmographic Details

HeadquartersRousset
Employee Range20
Year Founded2010
Last FundingDec 31, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?